Correspondence 0001213900-24-055789 from Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
Date: June 25, 2024 · CIK: 0001704287 · Accession: 0001213900-24-055789
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280253
Letter
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
June 25, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Bluejay Diagnostics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-280253
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on June 26, 2024, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes each of Brian O’Fahey and Helen Ferrall of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.
Please feel free to direct any questions or comments concerning this request to Mr. O’Fahey at (202) 637-6541 or Ms. Ferrall at (202) 804-7696, and once the Registration Statement has been declared effective, please notify Mr. O’Fahey or Ms. Ferrall by calling either of them at the same phone number.
Very truly yours,
Bluejay Diagnostics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
June 25, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Bluejay Diagnostics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-280253
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and
Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the “Company”) hereby requests
that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as
amended (the “Registration Statement”), and declare the Registration Statement effective as of 4:30 p.m., Eastern Time,
on June 26, 2024, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company
hereby authorizes each of Brian O’Fahey and Helen Ferrall of Hogan Lovells US LLP, counsel to the Company, to make such request
on its behalf.
Please feel free to direct any questions or comments
concerning this request to Mr. O’Fahey at (202) 637-6541 or Ms. Ferrall at (202) 804-7696, and once the Registration Statement
has been declared effective, please notify Mr. O’Fahey or Ms. Ferrall by calling either of them at the same phone number.
Very truly yours,
Bluejay Diagnostics, Inc.
/s/ Neil Dey
By:
Neil Dey
Title:
President and Chief Executive Officer